Findings aid antiviral drug discovery
Many viral infections, such as the common cold, cause mild illnesses that the body’s immune system eventually defeats. But when viruses cause severe disease, doctors have few options for effective treatment.
Studying mice with a variety of viral infections, scientists at Washington University School of Medicine in St. Louis have demonstrated a way to dial up the body’s innate immune defenses while simultaneously attacking a protein that many viruses rely on to replicate.
The findings, published Oct. 19 in Nature Immunology, reveal previously unknown weapons in the body’s antiviral immune arsenal and provide guidelines for designing drugs that could be effective against a broad range of viruses. The strategy involves enhancing the body’s interferon signaling system, long understood to be a vital part of antiviral defenses.
“We’ve discovered a new component of the interferon system,” said senior author Michael J. Holtzman, MD, the Selma and Herman Seldin Professor of Medicine. “It does something that other components don’t do, and it works on both sides of the fence: It dials up the body’s internal genes that fight viruses, and it attacks viral proteins directly.”
Holtzman and lead author Yong Zhang, PhD, an instructor in pulmonary medicine, suspect that the researchers’ one-two punch against the virus may explain the large difference in survival rates between control mice and mice genetically engineered to have increased signaling in their interferon systems.
When infected with encephalomyocarditis virus, which causes severe damage to vital organs including the brain, heart and pancreas, 97 percent of the genetically engineered mice survived, compared with none of the control mice. Even when the concentration of the injected virus was increased 100-fold, 82 percent of the genetically altered mice survived. And at 100-fold lower concentrations, all genetically engineered mice survived the infection, compared with only 25-28 percent of the control mice.
Holtzman pointed out that past research by other groups has shown that increasing the amount of interferon directly results in some improvements in fighting viruses, but not to the same extent as the current work. In addition, more modest improvements shown by other investigators usually are accompanied by autoimmune problems resulting from the chronically activated immune response. Despite the strong antiviral immune response seen in the new study, Holtzman and his colleagues reported no evidence of autoimmune disease in these mice.
The Latest on: Antiviral immune response
via Google News
The Latest on: Antiviral immune response
- Some people vaccinated against mumps may not be protected: Studyon September 7, 2019 at 10:07 am
New findings show the need to learn more about the immune system response to mumps and mumps vaccination. Mumps is a highly contagious viral disease that can spread rapidly among people in close ...
- The Role of Immunotherapy in Treating R/R mHCCon September 6, 2019 at 12:16 pm
And originally the reason for the design of the CheckMate-040 trial with distinct viral cohorts was the concern that there could be some immunologic phenomenon resulting in a fulminant hepatitis or an ...
- Mayor Jon Mitchell's statement on New Bedford Computer System Disruptionon September 4, 2019 at 5:36 pm
You do not have to be an expert however, to understand that no individual or organization on the planet is immune these days from a cyberattack ... cybersecurity threat and had been ramping up ...
- Vaping May Hamper the Lungs' Ability to Fend off Infectionson September 4, 2019 at 10:48 am
The patients, whose symptoms include difficulty breathing, chest pains, shortness of breath, and sometimes vomiting and diarrhea, have no known viral or bacterial infections ... the mice with a ...
- Mumps study shows immunity gaps among vaccinated peopleon September 3, 2019 at 10:47 am
Additional studies to characterize the immune response to wild-type and vaccine strains of mumps ... Symptoms of mumps include those common to viral illnesses – fatigue, body aches, headache – but a ...
- hnRNPA2B1: a nuclear DNA sensor in antiviral immunityon August 30, 2019 at 3:30 am
Pattern recognition receptors (PRRs) have critical roles in mediating innate immune responses ... How does hnRNPA2B1 initiate the DNA virus-induced IFN-I response? Wang et al. found that upon binding ...
- Study opens up new ways to understand the cause of chronic viral arthritison August 29, 2019 at 2:50 pm
Months after the initial infection, the researchers could detect glowing red cells still harboring viral RNA. The study ... We can study which proteins or other components of the immune response ...
- Viral priming of cell intrinsic innate antiviral signaling by the unfolded protein responseon August 29, 2019 at 2:19 am
to trigger the interferon (IFN)-mediated antiviral response 7. The innate immune response is generally associated to the activity of IFN leading to the induction of interferon-stimulated genes (ISGs) ...
- Study identifies new algorithm to treat viral infectionson August 27, 2019 at 12:29 am
Legler found that most of the viral proteases that could cut host proteins were from positive sense single-stranded RNA viruses. She also noticed that the proteins that were being cut were involved in ...
- More than just a viral video, the Salmon Cannon could be key to the species’ recoveryon August 25, 2019 at 12:52 pm
Research has shown no significant differences in injury rates, immune response, stress response, or g By Over the weekend, a 2014 video of a salmon being shot through a thin, flexible tube went viral.
via Bing News